📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The subdued post-boost spike-directed secondary IgG antibody response in Ugandan recipients of the Pfizer-BioNTech BNT162b2 vaccine has implications for local vaccination policies. (2024)

First Author: Ankunda V

Attributed to: Vaccinology funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2024.1325387

PubMed Identifier: 38469296

Publication URI: http://europepmc.org/abstract/MED/38469296

Type: Journal Article/Review

Volume: 15

Parent Publication: Frontiers in immunology

ISSN: 1664-3224